SynthesisBritish journal of clinical pharmacology2014

Comparative coronary risks of apixaban, rivaroxaban and dabigatran: a meta-analysis and adjusted indirect comparison.

Yoon K Loke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.